Jacques Corriveau is the founder of Ultivue. Ultivue has raised $50M in total funding. Latest round: Series D. Based in Cambridge, MA, USA.
Jacques Corriveau is the President and CEO of Ultivue, a company that advances precision medicine solutions. Ultivue combines multiplex biomarker analysis with traditional H&E for tissue phenotyping. The company recently completed a $50 million Series D financing round, with participation from new and existing investors.
Full founder directory · Investor directory · Company funding database · Fundraising library